$VNDA Recent Headlines What are hedge funds buyi
Post# of 144499
Posted On: 11/18/2013 7:32:21 PM
$VNDA Recent Headlines
What are hedge funds buying these days? 11:52 a.m. June 14, 2013 - Insider Monkey
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
Vanda Pharma shares up on positive trial data 9:07 a.m. Dec. 18, 2012 - MarketWatch.com
Vanda Pharma up 28% in premarket 8:29 a.m. Dec. 18, 2012 - Steve Gelsi
Vanda: progress with 24-hour-disorder drug 6:43 a.m. Oct. 15, 2012 - MarketWatch.com
Vanda to pay Lilly up to $100 mln 6:46 a.m. April 16, 2012 - MarketWatch.com
Obama’s spending plan is investors’ cue 12:01 a.m. Jan. 27, 2011 - Robert Powell
Monday’s biggest gaining and declining stocks 3:26 p.m. Nov. 15, 2010 - Robert Daniel
Wednesday's biggest gaining and declining stocks 5:13 p.m. March 10, 2010 - MarketWatch
Drug stocks pressured by J&J report; Avanir jumps 12:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Vanda Pharmaceuticals shares up 10% 8:44 a.m. Oct. 13, 2009 - Nick Godt
Vanda licenses schizophrenia drug to Novartis 2:56 a.m. Oct. 13, 2009 - Robert Daniel
Lilly and Vanda lead drug stocks south 11:41 a.m. Aug. 10, 2009 - Val Brickates Kennedy
Stocks in focus for Monday Aug. 10 6:53 p.m. Aug. 7, 2009 - MarketWatch
Drug stocks track broader market higher 12:28 p.m. May 14, 2009 - Val Brickates Kennedy
Drug stocks mixed; AstraZeneca gains on study 1:24 p.m. May 11, 2009 - Val Brickates Kennedy
Vanda, Titan rocket on drug approval 12:31 p.m. May 7, 2009 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:35 p.m. July 28, 2008 - MarketWatch
Vanda receives FDA not approvable letter for iloperidone 6:08 a.m. July 28, 2008 - William L. Watts
Vanda Pharma to meet with FDA to discuss decision 5:37 a.m. July 28, 2008 - Simon Kennedy
Simcere Reports a Loss - Analyst Blog 1:57 p.m. Today - Zacks.com
Vanda Pharmaceuticals (VNDA) Worth Watching: Stock Up 11.9% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Amarin, Sarepta And Vanda: Teachable Moments In Biotech 10:23 a.m. Nov. 17, 2013 - Seeking Alpha
Despite Shock Adcom Vote, Vanda Will Struggle To Remain Relevant 6:06 p.m. Nov. 15, 2013 - Seeking Alpha
Buffett Boosts Exxon, GE to Spin Off Lending Business: Market Recap 5:11 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
BlackBerry Gets Downgraded, Vanda’s Meteoric Rise, and 3 More Hot Stocks 1:53 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Analysts: Pandora Approaching a Turning Point and 3 More Research Notes to Check Out 10:38 a.m. Nov. 15, 2013 - Wall St. Cheat Sheet
UPDATE: FDA Advisory Committee Recommends Approval of HETLIOZ 5:04 a.m. Nov. 15, 2013 - benzinga.com
Vanda Pharma FDA Panel Live Blog 7:44 a.m. Nov. 14, 2013 - TheStreet.com
UPDATE: Vanda Pharmaceuticals Halted for FDA Advisory Committee to Review HETLIOZ NDA 6:06 a.m. Nov. 14, 2013 - benzinga.com
Positive FDA Feedback For Tasimelteon Bodes Well For Vanda 5:24 p.m. Nov. 13, 2013 - Seeking Alpha
Vanda Shoots Up Ahead of FDA Panel - Analyst Blog 4:30 p.m. Nov. 13, 2013 - Zacks.com
Today's Perilous Reversal Stock: Vanda Pharmaceuticals (VNDA) 9:45 a.m. Nov. 13, 2013 - TheStreet.com
Medivation Q3 Loss Narrower Than Expected - Analyst Blog 9:10 a.m. Nov. 13, 2013 - Zacks.com
Vanda Pharmaceuticals, Inc. (VNDA) Grabs Attention: Stock Shoots 95.9% - Tale of the Tape 8:51 a.m. Nov. 13, 2013 - Zacks.com
VNDA Stock Nearly Doubles in One Day 3:49 a.m. Nov. 13, 2013 - InvestorPlace.com
Barbarian At The Gate: Vanda Pharmaceuticals (VNDA) 1:23 p.m. Nov. 12, 2013 - TheStreet.com
Vanda’s Sleep Aid for the Blind Nears FDA Approval and 2 Other Hot Stocks to Watch 12:14 p.m. Nov. 12, 2013 - Wall St. Cheat Sheet
Interesting VNDA Put And Call Options For January 2016 1:42 p.m. Nov. 11, 2013 - TheStreet.com
VNDA January 2015 Options Begin Trading 11:23 a.m. Nov. 8, 2013 - TheStreet.com
FDA Advisory Committee Recommends Approval of HETLIOZ(TM) for the Treatment of Non-24-Hour-Disorder (Non-24) in the Totally Blind 10:55 p.m. Nov. 14, 2013 - PR Newswire
Vanda Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review HETLIOZ(TM) NDA 7:05 a.m. Nov. 14, 2013 - PR Newswire
SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Nov. 12, 2013 - ACCESSWIRE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Vanda Pharmaceuticals Reports Third Quarter 2013 Results 6:55 a.m. Nov. 7, 2013 - PR Newswire
Returning Value to Shareholders through Dividends, Strong Financial Results, and Regulatory Approvals - Research Report on Lilly, Illumina, Regeneron, Teva, and Vanda Pharmaceuticals 7:00 a.m. Oct. 24, 2013 - PR Newswire
Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013 6:00 p.m. Oct. 21, 2013 - PR Newswire
Vanda Pharmaceuticals Announces FDA Advisory Committee Meeting On November 14, 2013 3:01 p.m. Oct. 16, 2013 - PR Newswire
Vanda Pharmaceuticals to Present at the Stifel Nicolaus 2013 Healthcare Conference 4:00 p.m. Sept. 10, 2013 - PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 5:42 p.m. Aug. 23, 2013 - GlobeNewswire
UPCOMING DEADLINE: Levi & Korsinsky Reminds Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and of August 26, 2013 Deadline to Seek a Lead Plaintiff Position -- VNDA 11:49 a.m. Aug. 21, 2013 - GlobeNewswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 6:15 p.m. Aug. 16, 2013 - GlobeNewswire
VANDA PHARMACEUTICALS DEADLINE ALERT: Levi & Korsinsky Notifies Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 26, 2013 to Seek a Lead Plaintiff Position -- VNDA 12:06 p.m. Aug. 14, 2013 - GlobeNewswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Vanda Pharmaceuticals Inc. of Upcoming Deadline 5:53 p.m. Aug. 12, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 26, 2013 to Seek a Lead Plaintiff Position 4:00 p.m. Aug. 12, 2013 - BusinessWire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Vanda Pharmaceuticals, Inc. to Contact the Firm -- VNDA 9:10 p.m. Aug. 9, 2013 - GlobeNewswire
Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock 7:47 a.m. Aug. 7, 2013 - PR Newswire
Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock 3:01 p.m. Aug. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position 1:34 p.m. Aug. 6, 2013 - PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 5:50 p.m. Aug. 2, 2013 - GlobeNewswire
What are hedge funds buying these days? 11:52 a.m. June 14, 2013 - Insider Monkey
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
Vanda Pharma shares up on positive trial data 9:07 a.m. Dec. 18, 2012 - MarketWatch.com
Vanda Pharma up 28% in premarket 8:29 a.m. Dec. 18, 2012 - Steve Gelsi
Vanda: progress with 24-hour-disorder drug 6:43 a.m. Oct. 15, 2012 - MarketWatch.com
Vanda to pay Lilly up to $100 mln 6:46 a.m. April 16, 2012 - MarketWatch.com
Obama’s spending plan is investors’ cue 12:01 a.m. Jan. 27, 2011 - Robert Powell
Monday’s biggest gaining and declining stocks 3:26 p.m. Nov. 15, 2010 - Robert Daniel
Wednesday's biggest gaining and declining stocks 5:13 p.m. March 10, 2010 - MarketWatch
Drug stocks pressured by J&J report; Avanir jumps 12:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Vanda Pharmaceuticals shares up 10% 8:44 a.m. Oct. 13, 2009 - Nick Godt
Vanda licenses schizophrenia drug to Novartis 2:56 a.m. Oct. 13, 2009 - Robert Daniel
Lilly and Vanda lead drug stocks south 11:41 a.m. Aug. 10, 2009 - Val Brickates Kennedy
Stocks in focus for Monday Aug. 10 6:53 p.m. Aug. 7, 2009 - MarketWatch
Drug stocks track broader market higher 12:28 p.m. May 14, 2009 - Val Brickates Kennedy
Drug stocks mixed; AstraZeneca gains on study 1:24 p.m. May 11, 2009 - Val Brickates Kennedy
Vanda, Titan rocket on drug approval 12:31 p.m. May 7, 2009 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:35 p.m. July 28, 2008 - MarketWatch
Vanda receives FDA not approvable letter for iloperidone 6:08 a.m. July 28, 2008 - William L. Watts
Vanda Pharma to meet with FDA to discuss decision 5:37 a.m. July 28, 2008 - Simon Kennedy
Simcere Reports a Loss - Analyst Blog 1:57 p.m. Today - Zacks.com
Vanda Pharmaceuticals (VNDA) Worth Watching: Stock Up 11.9% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Amarin, Sarepta And Vanda: Teachable Moments In Biotech 10:23 a.m. Nov. 17, 2013 - Seeking Alpha
Despite Shock Adcom Vote, Vanda Will Struggle To Remain Relevant 6:06 p.m. Nov. 15, 2013 - Seeking Alpha
Buffett Boosts Exxon, GE to Spin Off Lending Business: Market Recap 5:11 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
BlackBerry Gets Downgraded, Vanda’s Meteoric Rise, and 3 More Hot Stocks 1:53 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Analysts: Pandora Approaching a Turning Point and 3 More Research Notes to Check Out 10:38 a.m. Nov. 15, 2013 - Wall St. Cheat Sheet
UPDATE: FDA Advisory Committee Recommends Approval of HETLIOZ 5:04 a.m. Nov. 15, 2013 - benzinga.com
Vanda Pharma FDA Panel Live Blog 7:44 a.m. Nov. 14, 2013 - TheStreet.com
UPDATE: Vanda Pharmaceuticals Halted for FDA Advisory Committee to Review HETLIOZ NDA 6:06 a.m. Nov. 14, 2013 - benzinga.com
Positive FDA Feedback For Tasimelteon Bodes Well For Vanda 5:24 p.m. Nov. 13, 2013 - Seeking Alpha
Vanda Shoots Up Ahead of FDA Panel - Analyst Blog 4:30 p.m. Nov. 13, 2013 - Zacks.com
Today's Perilous Reversal Stock: Vanda Pharmaceuticals (VNDA) 9:45 a.m. Nov. 13, 2013 - TheStreet.com
Medivation Q3 Loss Narrower Than Expected - Analyst Blog 9:10 a.m. Nov. 13, 2013 - Zacks.com
Vanda Pharmaceuticals, Inc. (VNDA) Grabs Attention: Stock Shoots 95.9% - Tale of the Tape 8:51 a.m. Nov. 13, 2013 - Zacks.com
VNDA Stock Nearly Doubles in One Day 3:49 a.m. Nov. 13, 2013 - InvestorPlace.com
Barbarian At The Gate: Vanda Pharmaceuticals (VNDA) 1:23 p.m. Nov. 12, 2013 - TheStreet.com
Vanda’s Sleep Aid for the Blind Nears FDA Approval and 2 Other Hot Stocks to Watch 12:14 p.m. Nov. 12, 2013 - Wall St. Cheat Sheet
Interesting VNDA Put And Call Options For January 2016 1:42 p.m. Nov. 11, 2013 - TheStreet.com
VNDA January 2015 Options Begin Trading 11:23 a.m. Nov. 8, 2013 - TheStreet.com
FDA Advisory Committee Recommends Approval of HETLIOZ(TM) for the Treatment of Non-24-Hour-Disorder (Non-24) in the Totally Blind 10:55 p.m. Nov. 14, 2013 - PR Newswire
Vanda Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review HETLIOZ(TM) NDA 7:05 a.m. Nov. 14, 2013 - PR Newswire
SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Nov. 12, 2013 - ACCESSWIRE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Vanda Pharmaceuticals Reports Third Quarter 2013 Results 6:55 a.m. Nov. 7, 2013 - PR Newswire
Returning Value to Shareholders through Dividends, Strong Financial Results, and Regulatory Approvals - Research Report on Lilly, Illumina, Regeneron, Teva, and Vanda Pharmaceuticals 7:00 a.m. Oct. 24, 2013 - PR Newswire
Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013 6:00 p.m. Oct. 21, 2013 - PR Newswire
Vanda Pharmaceuticals Announces FDA Advisory Committee Meeting On November 14, 2013 3:01 p.m. Oct. 16, 2013 - PR Newswire
Vanda Pharmaceuticals to Present at the Stifel Nicolaus 2013 Healthcare Conference 4:00 p.m. Sept. 10, 2013 - PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 5:42 p.m. Aug. 23, 2013 - GlobeNewswire
UPCOMING DEADLINE: Levi & Korsinsky Reminds Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and of August 26, 2013 Deadline to Seek a Lead Plaintiff Position -- VNDA 11:49 a.m. Aug. 21, 2013 - GlobeNewswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 6:15 p.m. Aug. 16, 2013 - GlobeNewswire
VANDA PHARMACEUTICALS DEADLINE ALERT: Levi & Korsinsky Notifies Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 26, 2013 to Seek a Lead Plaintiff Position -- VNDA 12:06 p.m. Aug. 14, 2013 - GlobeNewswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Vanda Pharmaceuticals Inc. of Upcoming Deadline 5:53 p.m. Aug. 12, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 26, 2013 to Seek a Lead Plaintiff Position 4:00 p.m. Aug. 12, 2013 - BusinessWire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Vanda Pharmaceuticals, Inc. to Contact the Firm -- VNDA 9:10 p.m. Aug. 9, 2013 - GlobeNewswire
Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock 7:47 a.m. Aug. 7, 2013 - PR Newswire
Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock 3:01 p.m. Aug. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position 1:34 p.m. Aug. 6, 2013 - PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 5:50 p.m. Aug. 2, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼